Related Experiment Video

Updated: Jun 5, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
09:28

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure

Published on: June 25, 2010

Research challenges in central nervous system manifestations of inborn errors of metabolism

P I Dickson1, A R Pariser, S C Groft

  • 1Department of Pediatrics, LA Biomedical Research Institute at Harbor-UCLA, 1124 W. Carson St, HH1, Torrance, CA 90502, USA. Pdickson@ucla.edu

Molecular Genetics and Metabolism
|December 24, 2010
PubMed

Insights

Translating therapies for inborn errors of metabolism affecting the central nervous system (CNS) faces unique challenges. This workshop explored novel strategies for CNS delivery, outcome assessment, and future treatment directions for these rare diseases.

Area of Science:

  • Neurology
  • Metabolic Disorders
  • Translational Research

Background:

  • Inborn errors of metabolism (IEMs) often manifest with severe central nervous system (CNS) complications.
  • Treating brain manifestations in IEMs presents significant translational research hurdles due to the blood-brain barrier and disease complexity.

Purpose of the Study:

  • To address key challenges in developing and translating therapies for CNS manifestations of IEMs.
  • To highlight innovative therapeutic strategies, CNS delivery methods, and outcome assessment techniques.
  • To foster collaboration among stakeholders for advancing IEM treatment.

Main Methods:

  • The content is based on proceedings from a dedicated workshop involving diverse experts.
  • Discussions encompassed scientific, ethical, and regulatory considerations.
  • Methods for measuring treatment effects and conducting clinical trials were reviewed.

Main Results:

  • Identified significant challenges in translating therapies for IEMs affecting the CNS.
  • Highlighted novel approaches for drug delivery to the brain and assessing therapeutic efficacy.
  • Emphasized the need for integrated strategies involving scientific, regulatory, and clinical communities.

Conclusions:

  • Advancing treatment for CNS manifestations of IEMs requires innovative approaches to therapy development and delivery.
  • Addressing scientific, ethical, and regulatory challenges is crucial for successful clinical translation.
  • Multidisciplinary collaboration is essential to overcome barriers and improve patient outcomes.

More Related Videos

Generation of Human Brain Organoids for Mitochondrial Disease Modeling08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...